Literature DB >> 22214848

Dopamine dysregulation in a mouse model of paroxysmal nonkinesigenic dyskinesia.

Hsien-yang Lee1, Junko Nakayama, Ying Xu, Xueliang Fan, Maha Karouani, Yiguo Shen, Emmanuel N Pothos, Ellen J Hess, Ying-Hui Fu, Robert H Edwards, Louis J Ptácek.   

Abstract

Paroxysmal nonkinesigenic dyskinesia (PNKD) is an autosomal dominant episodic movement disorder. Patients have episodes that last 1 to 4 hours and are precipitated by alcohol, coffee, and stress. Previous research has shown that mutations in an uncharacterized gene on chromosome 2q33-q35 (which is termed PNKD) are responsible for PNKD. Here, we report the generation of antibodies specific for the PNKD protein and show that it is widely expressed in the mouse brain, exclusively in neurons. One PNKD isoform is a membrane-associated protein. Transgenic mice carrying mutations in the mouse Pnkd locus equivalent to those found in patients with PNKD recapitulated the human PNKD phenotype. Staining for c-fos demonstrated that administration of alcohol or caffeine induced neuronal activity in the basal ganglia in these mice. They also showed nigrostriatal neurotransmission deficits that were manifested by reduced extracellular dopamine levels in the striatum and a proportional increase of dopamine release in response to caffeine and ethanol treatment. These findings support the hypothesis that the PNKD protein functions to modulate striatal neuro-transmitter release in response to stress and other precipitating factors.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22214848      PMCID: PMC3533379          DOI: 10.1172/JCI58470

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  52 in total

Review 1.  Synaptic organisation of the basal ganglia.

Authors:  J P Bolam; J J Hanley; P A Booth; M D Bevan
Journal:  J Anat       Date:  2000-05       Impact factor: 2.610

2.  Clinical characteristics of paroxysmal nonkinesigenic dyskinesia in Serbian family with Myofibrillogenesis regulator 1 gene mutation.

Authors:  Elka Stefanova; Ana Djarmati; Dragana Momcilović; Natasa Dragasević; Marina Svetel; Christine Klein; Vladimir S Kostić
Journal:  Mov Disord       Date:  2006-11       Impact factor: 10.338

3.  Anomalous interaction of the acetylcholine receptor protein with the nonionic detergent Triton X-114.

Authors:  P A Maher; S J Singer
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

4.  Simultaneous analyses of the neurochemical and behavioral effects of the norepinephrine reuptake inhibitor reboxetine in a rat model of antidepressant action.

Authors:  Michelle E Page; Kevin Brown; Irwin Lucki
Journal:  Psychopharmacology (Berl)       Date:  2002-11-09       Impact factor: 4.530

5.  Dopamine metabolism and receptor function after acute and chronic ethanol.

Authors:  A Reggiani; M L Barbaccia; P F Spano; M Trabucchi
Journal:  J Neurochem       Date:  1980-07       Impact factor: 5.372

6.  Myofibrillogenesis regulator 1 gene mutations cause paroxysmal dystonic choreoathetosis.

Authors:  Shirley Rainier; Donald Thomas; Debra Tokarz; Lei Ming; Melanie Bui; Erin Plein; Xinping Zhao; Rosemary Lemons; Roger Albin; Colin Delaney; David Alvarado; John K Fink
Journal:  Arch Neurol       Date:  2004-07

7.  Striatal increase of extracellular dopamine levels during dystonic episodes in a genetic model of paroxysmal dyskinesia.

Authors:  Melanie Hamann; Angelika Richter
Journal:  Neurobiol Dis       Date:  2004-06       Impact factor: 5.996

Review 8.  Caffeine as a psychomotor stimulant: mechanism of action.

Authors:  G Fisone; A Borgkvist; A Usiello
Journal:  Cell Mol Life Sci       Date:  2004-04       Impact factor: 9.261

9.  Ethanol metabolism and striatal dopamine turnover.

Authors:  M L Barbaccia; A Bosio; P F Spano; M Trabucchi
Journal:  J Neural Transm       Date:  1982       Impact factor: 3.575

Review 10.  The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders.

Authors:  Mario van der Stelt; Vincenzo Di Marzo
Journal:  Eur J Pharmacol       Date:  2003-11-07       Impact factor: 4.432

View more
  22 in total

1.  Synaptic UNC13A protein variant causes increased neurotransmission and dyskinetic movement disorder.

Authors:  Noa Lipstein; Nanda M Verhoeven-Duif; Francesco E Michelassi; Nathaniel Calloway; Peter M van Hasselt; Katarzyna Pienkowska; Gijs van Haaften; Mieke M van Haelst; Ron van Empelen; Inge Cuppen; Heleen C van Teeseling; Annemieke M V Evelein; Jacob A Vorstman; Sven Thoms; Olaf Jahn; Karen J Duran; Glen R Monroe; Timothy A Ryan; Holger Taschenberger; Jeremy S Dittman; Jeong-Seop Rhee; Gepke Visser; Judith J Jans; Nils Brose
Journal:  J Clin Invest       Date:  2017-02-13       Impact factor: 14.808

Review 2.  The epileptic and nonepileptic spectrum of paroxysmal dyskinesias: Channelopathies, synaptopathies, and transportopathies.

Authors:  Roberto Erro; Kailash P Bhatia; Alberto J Espay; Pasquale Striano
Journal:  Mov Disord       Date:  2017-01-16       Impact factor: 10.338

Review 3.  Genetic updates on paroxysmal dyskinesias.

Authors:  James Y Liao; Philippe A Salles; Umar A Shuaib; Hubert H Fernandez
Journal:  J Neural Transm (Vienna)       Date:  2021-04-30       Impact factor: 3.575

Review 4.  PRRT2-related disorders: further PKD and ICCA cases and review of the literature.

Authors:  Felicitas Becker; Julian Schubert; Pasquale Striano; Anna-Kaisa Anttonen; Elina Liukkonen; Eija Gaily; Christian Gerloff; Stephan Müller; Nicole Heußinger; Christoph Kellinghaus; Angela Robbiano; Anne Polvi; Simone Zittel; Tim J von Oertzen; Kevin Rostasy; Ludger Schöls; Tom Warner; Alexander Münchau; Anna-Elina Lehesjoki; Federico Zara; Holger Lerche; Yvonne G Weber
Journal:  J Neurol       Date:  2013-01-09       Impact factor: 4.849

5.  Protein mutated in paroxysmal dyskinesia interacts with the active zone protein RIM and suppresses synaptic vesicle exocytosis.

Authors:  Yiguo Shen; Woo-Ping Ge; Yulong Li; Arisa Hirano; Hsien-Yang Lee; Astrid Rohlmann; Markus Missler; Richard W Tsien; Lily Yeh Jan; Ying-Hui Fu; Louis J Ptáček
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-17       Impact factor: 11.205

6.  PRRT2 links infantile convulsions and paroxysmal dyskinesia with migraine.

Authors:  Robin Cloarec; Nadine Bruneau; Gabrielle Rudolf; Annick Massacrier; Manal Salmi; Marc Bataillard; Clotilde Boulay; Roberto Caraballo; Natalio Fejerman; Pierre Genton; Edouard Hirsch; Alasdair Hunter; Gaetan Lesca; Jacques Motte; Agathe Roubertie; Damien Sanlaville; Sau-Wei Wong; Ying-Hui Fu; Jacques Rochette; Louis J Ptácek; Pierre Szepetowski
Journal:  Neurology       Date:  2012-10-17       Impact factor: 9.910

Review 7.  Animal models for dystonia.

Authors:  Bethany K Wilson; Ellen J Hess
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338

8.  Loss of the dystonia gene Thap1 leads to transcriptional deficits that converge on common pathogenic pathways in dystonic syndromes.

Authors:  Natalie M Frederick; Parth V Shah; Alessandro Didonna; Monica R Langley; Anumantha G Kanthasamy; Puneet Opal
Journal:  Hum Mol Genet       Date:  2019-04-15       Impact factor: 6.150

9.  Dopamine Receptor Agonist Treatment of Idiopathic Dystonia: A Reappraisal in Humans and Mice.

Authors:  Xueliang Fan; Yuping Donsante; H A Jinnah; Ellen J Hess
Journal:  J Pharmacol Exp Ther       Date:  2018-01-18       Impact factor: 4.030

10.  Mutations in the gene PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions.

Authors:  Hsien-Yang Lee; Yong Huang; Nadine Bruneau; Patrice Roll; Elisha D O Roberson; Mark Hermann; Emily Quinn; James Maas; Robert Edwards; Tetsuo Ashizawa; Betul Baykan; Kailash Bhatia; Susan Bressman; Michiko K Bruno; Ewout R Brunt; Roberto Caraballo; Bernard Echenne; Natalio Fejerman; Steve Frucht; Christina A Gurnett; Edouard Hirsch; Henry Houlden; Joseph Jankovic; Wei-Ling Lee; David R Lynch; Shehla Mohammed; Ulrich Müller; Mark P Nespeca; David Renner; Jacques Rochette; Gabrielle Rudolf; Shinji Saiki; Bing-Wen Soong; Kathryn J Swoboda; Sam Tucker; Nicholas Wood; Michael Hanna; Anne M Bowcock; Pierre Szepetowski; Ying-Hui Fu; Louis J Ptáček
Journal:  Cell Rep       Date:  2011-12-15       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.